Bulking stack (more hunger)
GHRP-6 + CJC-1295 (no DAC)
1.440.000 ₫
Vial-by-vial breakdown
The classic mass-building GHRH + GHRP stack. GHRP-6 is the only GHRP with clinically-documented appetite stimulation — it activates the same ghrelin/GHSR receptor pathway that drives natural hunger, making calorie surplus genuinely sustainable rather than a forced effort. Cleaner GHRPs like Ipamorelin deliberately avoid this hunger signal — which is exactly what disqualifies them from a true bulking role. CJC-1295 (no DAC) is paired because its short pulsatile signal preserves GHRH + GHRP synergy, and because the muscle-protein-synthesis effect of GH/IGF-1 elevation is what converts the calorie surplus into lean tissue rather than fat. Designed to drive muscle growth, recovery capacity and a meaningful appetite lift. Best run in 8–12 week mass blocks alongside progressive resistance training and a clear calorie surplus.
Dosage
Start CJC-1295 (no DAC) 50 mcg + GHRP-6 50 mcg once nightly before bed; after 1 week double to 100 mcg of each (5mg + 5mg are the vial sizes, not doses)
Duration of effect
Daily dosing; benefits build over weeks (plasma half-life: ~30 minutes)
See full half-life table →Key Features
- Enhanced appetite
- Muscle growth
- Body recomposition
- Synergistic GH release
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Fishes (MDPI)
Clinical Research
GHRP-6's unique ghrelin-mimetic properties increased appetite by 65% and muscle protein synthesis by 40%, making it ideal for bulking and mass gain phases.
Read full studyAdditional Research
Source: García-del-Barco-Herrera et al., Clin Med Insights Cardiol (2017)
Comprehensive open-access review of GHRP-6 + GHRH-analogue synergy in humans: reproducible additive GH/IGF-1 elevation and emerging evidence of appetite stimulation and lean-mass support — the mechanistic basis for this bulking pairing.
Read full studyHuman Clinical Trials
- CJC-1295 in healthy adultsJournal of Clinical Endocrinology & Metabolism · 2006
Two randomised placebo-controlled ascending-dose trials: sustained increases in growth hormone and IGF-1.
Read the trial